FARALLON CAPITAL MANAGEMENT LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$15.4B
Holdings
131
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | QUREUNIQURE NV | 300,000 | $10.8B | 70.52% | |
| 102 | —CASCADE ACQUISITION CORP | 990,000 | $10.3B | 67.31% | |
| 103 | —KINNATE BIOPHARMA INC | 250,000 | $9.9B | 64.70% | |
| 104 | BDQMALBIREO PHARMA INC | 250,000 | $9.4B | 61.02% | |
| 105 | SURFUSDSURFACE ONCOLOGY INC | 1,000,000 | $9.2B | 60.12% | |
| 106 | GOSS 5 06/01/27GOSSAMER BIO INC | 10,000,000 | $9.0B | 58.76% | |
| 107 | —ACACIA COMMUNICATIONS INC | 100,000 | $7.3B | 47.47% | |
| 108 | —FIVE PRIME THERAPEUTICS INC | 400,000 | $6.8B | 44.27% | |
| 109 | COGTCOGENT BIOSCIENCES INC | 600,000 | $6.7B | 43.84% | |
| 110 | IMGNEURIMMUNOGEN INC | 1,000,000 | $6.5B | 41.97% | |
| 111 | —RADIUS HEALTH INC | 6,783,000 | $6.0B | 39.00% | |
| 112 | MRVLMARVELL TECHNOLOGY GROUP LTD | 125,000 | $5.9B | 38.67% | Call |
| 113 | —CURIS INC | 725,000 | $5.9B | 38.63% | |
| 114 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 3,522,000 | $5.9B | 38.58% | |
| 115 | STTKSHATTUCK LABS INC | 100,000 | $5.2B | 34.10% | |
| 116 | OPHTEURIVERIC BIO INC | 754,740 | $5.2B | 33.93% | |
| 117 | TGTXTG THERAPEUTICS INC | 100,000 | $5.2B | 33.85% | |
| 118 | ARWRARROWHEAD PHARMACEUTICALS IN | 67,600 | $5.2B | 33.75% | |
| 119 | YB4PSAVARA INC | 4,452,086 | $5.1B | 33.31% | |
| 120 | —HUMANCO ACQUISITION CORP | 400,000 | $4.4B | 28.68% | |
| 121 | MASS908 DEVICES INC | 75,000 | $4.3B | 27.79% | |
| 122 | FDMT4D MOLECULAR THERAPEUTICS IN | 100,000 | $4.1B | 26.97% | |
| 123 | KURAKURA ONCOLOGY INC | 125,000 | $4.1B | 26.56% | |
| 124 | EQEQUILLIUM INC | 700,000 | $3.7B | 24.37% | |
| 125 | —ISIS PHARMACEUTICALS INC DEL | 2,500,000 | $2.7B | 17.78% | |
| 126 | NVLSEURALPINE IMMUNE SCIENCES INC | 200,000 | $2.5B | 16.40% | |
| 127 | IVAINVENTIVA SA | 160,000 | $2.3B | 15.09% | |
| 128 | SPRYSILVERBACK THERAPEUTICS INC | 47,620 | $2.2B | 14.36% | |
| 129 | —BROADMARK RLTY CAP INC | 7,174,613 | $1.9B | 12.60% | |
| 130 | GOLGBPGOL LINHAS AEREAS INTELIGENT | 85,838 | $843.0M | 5.48% | |
| 131 | —CEREVEL THERAPEUTICS HLDNG I | 134,175 | $758.0M | 4.93% |
PreviousPage 2 of 2